Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fondsfinans is a prominent Norwegian investment firm and asset manager that specializes in actively managed equity and fixed-income funds. The company is particularly recognized in the life sciences sector for its "Fondsfinans Global Helse" fund, which focuses on global investments in pharmaceuticals, biotechnology, and medical technology. Historically, the Fondsfinans group has also served as a key financial advisor and bookrunner for numerous Nordic biotech companies, including Algeta, Photocure, and PCI Biotech. Headquartered in Oslo and owned by the Erik Must family, the firm plays a significant role in the financing and development of the Nordic healthcare ecosystem. Its investment approach emphasizes long-term value creation and rigorous ESG integration across its portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fondsfinans.